Company Duopharma Biotech

Equities

DPHARMA

MYL7148OO009

Pharmaceuticals

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
1.18 MYR +0.85% Intraday chart for Duopharma Biotech +1.72% -6.35%

Business Summary

Duopharma Biotech Berhad is a Malaysia-based pharmaceutical company. The Company is engaged in the manufacturing and distribution of pharmaceutical products. Its business segments include Consumer Healthcare (CHC), Ethical Classic Business (ECB) and Ethical Specialty Business (ESB). The CHC is engaged in the manufacturing, marketing and distribution of over-the-counter products, such as vitamins and supplements, analgesics, eyecare and antacids to the domestic, regional and international markets. Its CHC brands include Flavettes, CHAMPS, Uphamol and Eye Glo. The ECB comprises more than 300 generic drugs manufactured by the Company, such as Crystorvas, Prelica and Omesec, among others. The ESB is focused on drugs for targeted conditions, as well as medical devices and consumables. It has also diversified into the biosimilars space with technology and commercialization collaborations with international partners. ERYSAA, Basalog One and Zuhera are a few commercialized biosimilar brands.

Sales per Business

MYR in Million2022Weight2023Weight Delta
Pharmaceutical Products
100.0 %
697 100.0 % 705 100.0 % +1.15%

Sales per region

MYR in Million2022Weight2023Weight Delta
Malaysia
100.0 %
697 100.0 % 705 100.0 % +1.15%

Managers

Managers TitleAgeSince
Chief Executive Officer 60 17-12-27
Director of Finance/CFO 59 00-08-06
Investor Relations Contact - -
Comptroller/Controller/Auditor 40 17-12-27
Corporate Officer/Principal 52 16-09-04
Corporate Officer/Principal 55 97-12-31
General Counsel 57 17-12-27

Members of the board

Members of the board TitleAgeSince
Chairman 72 16-04-04
Chief Executive Officer 60 17-12-27
Director/Board Member 71 16-05-31
Director/Board Member 63 23-05-31
Director/Board Member 67 18-03-07
Director/Board Member 65 16-08-31
Director/Board Member 71 17-12-27
Director/Board Member 69 16-11-15
Director/Board Member 74 19-09-05

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 961,942,000 435,298,973 ( 45.25 %) 0 45.25 %

Shareholders

NameEquities%Valuation
Employees Provident Fund
8.598 %
82,710,407 8.598 % 21 M RM
Permodalan Nasional Bhd.
6.669 %
64,150,451 6.669 % 16 M RM
Lembaga Tabung Haji
1.901 %
18,283,500 1.901 % 5 M RM
Billion Victory Sdn. Bhd.
1.566 %
15,068,798 1.566 % 4 M RM
Bank Negara Malaysia
1.318 %
12,679,329 1.318 % 3 M RM
Public Mutual Bhd.
1.049 %
10,092,037 1.049 % 3 M RM
Eastspring Investments Bhd.
0.9842 %
9,467,646 0.9842 % 2 M RM
Manulife Investment Management (M) Bhd.
0.7429 %
7,146,712 0.7429 % 2 M RM
Eastspring Investments (Singapore) Ltd.
0.7341 %
7,061,226 0.7341 % 2 M RM
Great Eastern Life Assurance Co. Ltd.
0.5456 %
5,248,364 0.5456 % 1 M RM

Holdings

NameEquities%Valuation
806,450 7.55% 3,749,952 $

Company contact information

Duopharma Biotech Bhd.

Lot 2599, Jalan Seruling 59 Kawasan 3

41200, Klang

+

http://www.duopharmabiotech.com
address Duopharma Biotech(DPHARMA)
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.26 MYR
Average target price
1.475 MYR
Spread / Average Target
+17.06%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. DPHARMA Stock
  4. Company Duopharma Biotech